My research focuses on alternative RNA splicing, leukemia pathogenesis, and chromosomal instability, with an emphasis on uncovering how splicing dysregulation and genome instability drive disease progression. I integrate molecular biology, multi-omics, and bioinformatics approaches to identify key regulatory mechanisms and therapeutic vulnerabilities, particularly in acute myeloid leukemia. My academic interests also include synthetic lethality, RNA-based regulation, and the development of targeted treatment strategies for hematologic malignancies.